$3.45
+0.06 (+1.77%)
Open$3.19
Previous Close$3.39
Day High$3.57
Day Low$3.14
52W High$9.99
52W Low$1.98
Volume—
Avg Volume19.7K
Market Cap39.70M
P/E Ratio—
EPS$-0.87
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,182.0% upside
Current
$3.45
$3.45
Target
$44.23
$44.23
$32.29
$44.23 avg
$55.91
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 16.90M | 15.57M | 15.33M |
| Net Income | 2.99M | 2.88M | 3.11M |
| Profit Margin | 17.7% | 18.5% | 20.3% |
| EBITDA | 3.97M | 4.34M | 3.61M |
| Free Cash Flow | 3.54M | 3.27M | 3.55M |
| Rev Growth | +19.1% | +9.8% | -6.9% |
| Debt/Equity | 0.36 | 0.34 | 0.37 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |